GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 136 filers reported holding GENOMIC HEALTH INC in Q4 2017. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,030,000 | +25.0% | 30,105 | +17.2% | 0.06% | +20.0% |
| Q3 2017 | $824,000 | 0.0% | 25,680 | +1.4% | 0.05% | -2.0% |
| Q2 2017 | $824,000 | +1.6% | 25,330 | -1.6% | 0.05% | +4.1% |
| Q1 2017 | $811,000 | +30.2% | 25,740 | +21.5% | 0.05% | +25.6% |
| Q4 2016 | $623,000 | +2.3% | 21,187 | +0.6% | 0.04% | -13.3% |
| Q3 2016 | $609,000 | +25.6% | 21,065 | +12.5% | 0.04% | +25.0% |
| Q2 2016 | $485,000 | +4.8% | 18,725 | +0.1% | 0.04% | +2.9% |
| Q1 2016 | $463,000 | -33.5% | 18,700 | -5.5% | 0.04% | -30.0% |
| Q4 2015 | $696,000 | +35.1% | 19,785 | -18.7% | 0.05% | +31.6% |
| Q3 2015 | $515,000 | +13.7% | 24,350 | +45.6% | 0.04% | +22.6% |
| Q2 2015 | $453,000 | 0.0% | 16,725 | 0.0% | 0.03% | 0.0% |
| Q1 2015 | $453,000 | -11.0% | 16,725 | +5.1% | 0.03% | -13.9% |
| Q4 2014 | $509,000 | +41.8% | 15,920 | +25.6% | 0.04% | +38.5% |
| Q3 2014 | $359,000 | +3.5% | 12,675 | 0.0% | 0.03% | +8.3% |
| Q2 2014 | $347,000 | – | 12,675 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 13,770,982 | $433,648,000 | 3.55% |
| Camber Capital Management LP | 2,458,100 | $77,406,000 | 3.14% |
| EMORY UNIVERSITY | 76,851 | $2,420,000 | 2.28% |
| Tributary Capital Management, LLC | 294,962 | $9,288,000 | 0.91% |
| Motley Fool Asset Management LLC | 131,935 | $4,155,000 | 0.90% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,607,649 | $50,625,000 | 0.71% |
| UNIVERSITY OF NOTRE DAME DU LAC | 79,693 | $2,510,000 | 0.63% |
| Motley Fool Wealth Management, LLC | 129,245 | $4,070,000 | 0.39% |
| Spark Investment Management LLC | 189,700 | $5,973,000 | 0.38% |
| TFS CAPITAL LLC | 35,026 | $1,103,000 | 0.36% |